RemeOs is the first and only bioresorbable metal implant approved by the FDA, with successful clinical trials conducted in the ankle, according to a March 30 press release.
Bioretec plans to launch the screw in the U.S. in collaboration with hospitals and professionals specializing in ankle fractures.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
